Richard Gregory
Director/Board Member at CANBRIDGE PHARMACEUTICALS INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Neil Warma | M | 61 | 3 years | |
Qian Ma | F | - | 3 years | |
James Xue | M | 55 | 6 years | |
James Geraghty | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
Lan Hu | F | 53 | - | |
Josh Mandel-Brehm | M | 41 | 3 years | |
Gerald Cox | M | - | - | |
Maggie Shafmaster | M | 65 | 3 years | |
Lan Hu | M | 55 | 2 years | |
Peng Kuan Chan | M | 60 | 3 years | |
Zhang Wei | M | - | - | |
Jenny Tao | F | - | - | |
Chris Chen | F | - | - | |
Rebecca Zhang | F | - | - | |
Dan Li | F | - | - | |
Mao Stella | F | - | 4 years | |
Liu Lily | F | - | - | |
Jeff Lau | M | - | - | |
Minnie Ke | F | - | - | |
Marcelo Cheresky | M | - | - | |
Hu Tianxin | M | - | - | |
Edward Hu | M | 61 | 2 years | |
Yi Jun Lu | M | 50 | 4 years | |
Yun Xiang Zhu | M | 60 | 4 years | |
Daniel Geffken | M | 67 | 7 years | |
Pauline Li | M | - | 2 years | |
Kan Chen | M | 42 | 4 years | |
Wai Chiu Wong | M | 69 | 2 years | |
Ernest D. Bush | M | - | 6 years | |
Gavin Malenfant | M | 61 | 3 years | |
Larry Altstiel | M | 74 | 2 years | |
Isabella Zhao | F | - | - | |
Glenn Hassan | M | 46 | 5 years | |
David Wishart | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Daniel Junius | M | 71 | 13 years | |
David B. Johnston | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
Mark Enyedy | M | 60 | 8 years | |
Elliot Goldstein | M | 73 | 7 years | |
Gail Farfel | M | 60 | 1 years | |
Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Daniel Paul Regan | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
University of Massachusetts
| 17 years |
Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
William Sibold | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Steve Vinter | M | - |
University of Massachusetts
| 3 years |
Jean S. K. Lee | M | - |
University of Massachusetts
| 4 years |
Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
Blaine McKee | M | 59 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 17 years |
Stuart Arbuckle | M | 58 | 6 years | |
Yamo Deniz | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 4 years |
Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
Sarah Kiely | F | - | 7 years | |
Thomas Ryll | M | 64 | 6 years | |
Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
Anthony Giovinazzo | M | 67 | 3 years | |
Andy Bartlett | M | - |
University of Massachusetts
| 9 years |
Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
Howard H. Pien | M | 66 | 9 years | |
Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
David G. Foster | M | - | 3 years | |
Nicole Onetto | M | 71 | 11 years | |
Joseph J. Villafranca | M | 79 | 14 years | |
Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Brian J. Krol | M | - |
University of Massachusetts
| 7 years |
Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
Wayne Boulais | M | 60 |
University of Massachusetts
| 7 years |
Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
Carlos Patricio | M | - |
University of Massachusetts
| 4 years |
Michael Buettner | M | - |
University of Massachusetts
| 3 years |
Daniel J. Riccio | M | 61 |
University of Massachusetts
| 4 years |
David Scott Dusenbury | M | - |
University of Massachusetts
| 4 years |
Sue Salvemini | F | - |
University of Massachusetts
| 4 years |
Paul J. Smith | M | - |
University of Massachusetts
| 4 years |
Mark Shawn Frank | M | 62 |
University of Massachusetts
| 4 years |
Juan Iturregui | M | 59 |
University of Massachusetts
| 3 years |
Vince Prainito | M | - |
University of Massachusetts
| 4 years |
Kathleen Cahill Gaffney | F | 63 |
University of Massachusetts
| 4 years |
Maggie M. Burke | F | - |
University of Massachusetts
| 4 years |
Samuel F. H. Jeffries | M | 60 |
University of Massachusetts
| 4 years |
John Schwartz | M | - |
University of Massachusetts
| 4 years |
Gene DiPoto | M | - |
University of Massachusetts
| 4 years |
Peter Martin Hellwig | M | 57 |
University of Massachusetts
| 4 years |
Peter Kawa | M | - |
University of Massachusetts
| 4 years |
Dave Kelly | M | - |
University of Massachusetts
| 4 years |
Michael Turits | M | - |
University of Massachusetts
| 11 years |
Jim Miller | M | - |
University of Massachusetts
| 4 years |
Svetlana Yuryevna Barmina | F | 56 |
University of Massachusetts
| 4 years |
Allen Fuqua | M | - |
University of Massachusetts
| 2 years |
Stephen Cavanaugh | M | - |
University of Massachusetts
| 4 years |
Güçlü Toker | M | 62 |
University of Massachusetts
| 4 years |
Jim McElroy | M | - |
University of Massachusetts
| 4 years |
Dan Albert McKenna | M | - |
University of Massachusetts
| 4 years |
Steve Janko | M | - |
University of Massachusetts
| 4 years |
Ralph Axel | M | - |
University of Massachusetts
| 4 years |
Dean J. Breda | M | - |
University of Massachusetts
| 4 years |
James Lampert | M | - |
University of Massachusetts
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 64 | 64.00% |
China | 26 | 26.00% |
Canada | 11 | 11.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Gregory
- Personal Network